What ceftriaxone dose should be given to a 5-year-old child with community-acquired pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ceftriaxone Dosing for 5-Year-Old with Pneumonia

For a 5-year-old child with community-acquired pneumonia, administer ceftriaxone 50-100 mg/kg/day IV/IM, given either once daily or divided every 12-24 hours, with 50 mg/kg once daily being the most commonly validated regimen for typical CAP.

Recommended Dosing Algorithm

Standard CAP (Non-Severe)

  • 50 mg/kg once daily IV or IM 1, 2
  • This is the most extensively studied regimen in pediatric pneumonia 3, 4, 5
  • Maximum daily dose: 2 grams

Severe CAP or Suspected Resistant Pneumococcus

  • 100 mg/kg/day (divided every 12-24 hours) 1
  • Use this higher dose when:
    • Patient requires ICU admission
    • Suspected penicillin-resistant S. pneumoniae (MIC ≥4.0 µg/mL)
    • Severe respiratory distress or complications
  • Maximum daily dose: 4 grams

Evidence Supporting Once-Daily Dosing

The 50 mg/kg once-daily regimen is particularly well-validated:

  • Pharmacokinetic data shows trough concentrations at 24 hours (6.6 ± 0.9 mcg/mL) remain well above MIC90 for both S. pneumoniae and H. influenzae throughout the dosing interval 6
  • Clinical cure rates of 94-97% achieved with once-daily dosing in multiple pediatric pneumonia studies 3, 4, 5
  • The long half-life (4.6 hours in children) supports once-daily administration 2

Practical Considerations

Route of Administration

  • IV preferred for hospitalized patients
  • IM acceptable for outpatient or step-down therapy after initial stabilization 4
  • IM concentrations peak at 2-3 hours with complete absorption 2

Duration of Therapy

  • 3 days minimum if clinical stability achieved by day 3 7, 8
  • 5-7 days total for uncomplicated CAP 1, 7
  • Clinical stability = afebrile, improved respiratory symptoms, tolerating oral intake

Outpatient Transition Strategy

After 24-48 hours of clinical improvement with IV/IM ceftriaxone, consider:

  • Continuing once-daily IM ceftriaxone as outpatient 4
  • Switching to oral amoxicillin 90 mg/kg/day 1

Important Caveats

Add macrolide coverage (azithromycin or clarithromycin) if:

  • Age >5 years with atypical features (Mycoplasma, Chlamydophila)
  • No response to beta-lactam alone after 48-72 hours 1

Add vancomycin or clindamycin if:

  • Suspected S. aureus (post-influenza, necrotizing features, empyema) 1
  • Base choice on local MRSA susceptibility patterns

Avoid calcium-containing IV solutions within 48 hours of ceftriaxone in any patient due to precipitation risk 2

Dosing Calculation Example

For a 5-year-old weighing 20 kg:

  • Standard dose: 50 mg/kg × 20 kg = 1000 mg (1 gram) once daily
  • Severe CAP: 100 mg/kg × 20 kg = 2000 mg (2 grams) once daily or 1 gram every 12 hours

The FDA label and IDSA/PIDS guidelines align on these dosing ranges, with the 50-100 mg/kg/day range providing flexibility based on severity 1, 2. The once-daily regimen at 50 mg/kg offers optimal convenience, proven efficacy, and potential for early hospital discharge with outpatient completion 3, 4.

Related Questions

What is the appropriate ceftriaxone dose for a 39‑kg child?
What is the appropriate ceftriaxone dose for a 2-year-old girl with pneumonia?
Can ceftriaxone and piperacillin‑tazobactam be combined in a 13‑year‑old girl with severe community‑acquired pneumonia and a pleural effusion?
What is the appropriate ceftriaxone dose for a 17-year-old male weighing 52 kg?
What intramuscular dose of Rocephin (ceftriaxone) is appropriate for an adult with community‑acquired pneumonia?
In a patient allergic to penicillins and cephalosporins with a urine culture growing Proteus mirabilis and Pseudomonas aeruginosa, and given the susceptibility profile (Proteus mirabilis susceptible to ampicillin, ampicillin/sulbactam, cefepime, ceftazidime, ceftriaxone, ciprofloxacin, gentamicin, levofloxacin, meropenem, piperacillin/tazobactam, and trimethoprim‑sulfamethoxazole; intermediate to cefazolin; resistant to nitrofurantoin; Pseudomonas aeruginosa resistant to ciprofloxacin, levofloxacin, and meropenem; intermediate to cefepime; susceptible to aztreonam, amikacin, ceftazidime, piperacillin/tazobactam, and tobramycin), what definitive antimicrobial regimen should be used?
What diet and lifestyle interventions does integrative medicine recommend to promote intestinal health?
What laboratory abnormalities are associated with elevated cortisol levels?
Does lactate dehydrogenase increase during pregnancy?
Can a kidney transplant be performed during the same operative session as a radical nephrectomy for renal cell carcinoma?
What is the pathology of ischemic stroke?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.